The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ICML 2019 | Moving towards chemo-free regimens in CLL
Michael Hallek
• 19 Jun 2019
Michael Hallek, MD, PhD, University of Cologne, Cologne, Germany, discusses the emergence of chemotherapy-free regimens in chronic lymphocytic leukemia (CLL), highlighting the situtations where this approach wouldn’t be used. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.
